Science and Neurosoft partner on BCI development
• Agreement provides access to a clinical-grade neural recording platform designed to lower development costs and support human trials. • Science Corporation andNeurosoft Bioelectr
• Agreement provides access to a clinical-grade neural recording platform designed to lower development costs and support human trials. • Science Corporation andNeurosoft Bioelectr
• China’s NeuroXess accelerates to human trials, aiming to outpace Neuralink. • Founded in 2021, the Shanghai-based firm reports successful invasive BCI trials. • A paralyzed patie